Two partners from Schiff Hardin LLP’s Product Liability & Mass Torts Practice Group spoke about the future of mass tort litigation in the United States at the Lloyd’s Old Library in London on October 20, 2015.  Paul A. Scrudato and Edward Casmere discussed the state of mass tort litigation and its future with a group of London-based insurance professionals in the historic Old Library at Lloyds on Lime Street in London.  The topics included nanotechnology, pharmaceuticals and medical devices, e-cigarettes, wearable technology, and fracking.

Continue Reading Schiff Hardin Partners Present on the Future of Mass Tort Litigation at Lloyd’s Old Library in London

The Food and Drug Administration (FDA) recently proposed new regulations on electronic cigarettes (“e-cigarettes”), including banning the sale of such products to children under age 18.  But according to more than two dozen state attorneys general, the FDA’s proposed regulations do not go far enough.
Continue Reading Proposed New E-Cigarette Regulations Not Sufficient For More Than Two Dozen State Attorneys General

A mere ten years since their introduction, the “electronic nicotine delivery systems” (ENDS) industry is expected to reach $3 billion by 2015.  As the market for these devices grows, however, so does the potential for tort litigation.  E-cigarettes, “vape pens,” and other ENDS use a heating device to atomize liquid nicotine as well as propylene glycol, glycerin, and flavors.  This allows the user, or “vaper,” to inhale nicotine without the combustion process found in traditional cigarettes. 
Continue Reading As E-Cigarette Market Grows, Regulations and Litigation Risks Multiply